CA2476382A1 - Surveillance de la temperature cerebrale - Google Patents
Surveillance de la temperature cerebrale Download PDFInfo
- Publication number
- CA2476382A1 CA2476382A1 CA002476382A CA2476382A CA2476382A1 CA 2476382 A1 CA2476382 A1 CA 2476382A1 CA 002476382 A CA002476382 A CA 002476382A CA 2476382 A CA2476382 A CA 2476382A CA 2476382 A1 CA2476382 A1 CA 2476382A1
- Authority
- CA
- Canada
- Prior art keywords
- blood
- catheter
- brain
- infusion
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002490 cerebral effect Effects 0.000 title description 3
- 210000004556 brain Anatomy 0.000 claims abstract description 238
- 238000000034 method Methods 0.000 claims abstract description 90
- 210000004369 blood Anatomy 0.000 claims description 364
- 239000008280 blood Substances 0.000 claims description 364
- 238000001802 infusion Methods 0.000 claims description 249
- 239000003978 infusion fluid Substances 0.000 claims description 157
- 238000001816 cooling Methods 0.000 claims description 112
- 210000001367 artery Anatomy 0.000 claims description 103
- 238000000605 extraction Methods 0.000 claims description 81
- 210000004204 blood vessel Anatomy 0.000 claims description 74
- 238000010438 heat treatment Methods 0.000 claims description 58
- 230000002631 hypothermal effect Effects 0.000 claims description 57
- 230000001105 regulatory effect Effects 0.000 claims description 57
- 210000003462 vein Anatomy 0.000 claims description 49
- 230000004087 circulation Effects 0.000 claims description 31
- 239000000243 solution Substances 0.000 claims description 27
- 238000005086 pumping Methods 0.000 claims description 24
- 210000000709 aorta Anatomy 0.000 claims description 20
- 210000004731 jugular vein Anatomy 0.000 claims description 19
- 230000033228 biological regulation Effects 0.000 claims description 16
- 230000001419 dependent effect Effects 0.000 claims description 16
- 230000002093 peripheral effect Effects 0.000 claims description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- 230000001681 protective effect Effects 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 12
- 230000003247 decreasing effect Effects 0.000 claims description 11
- 230000017531 blood circulation Effects 0.000 claims description 10
- 210000004351 coronary vessel Anatomy 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 210000001715 carotid artery Anatomy 0.000 claims description 6
- 210000005259 peripheral blood Anatomy 0.000 claims description 5
- 239000011886 peripheral blood Substances 0.000 claims description 5
- 210000003752 saphenous vein Anatomy 0.000 claims description 5
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 210000002376 aorta thoracic Anatomy 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 230000036760 body temperature Effects 0.000 abstract description 14
- 239000007789 gas Substances 0.000 description 27
- 230000010412 perfusion Effects 0.000 description 20
- 230000007423 decrease Effects 0.000 description 11
- 230000001276 controlling effect Effects 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- 208000006011 Stroke Diseases 0.000 description 8
- 238000006213 oxygenation reaction Methods 0.000 description 8
- 208000010496 Heart Arrest Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000001627 detrimental effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000002411 adverse Effects 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 4
- 230000005574 cross-species transmission Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 210000001105 femoral artery Anatomy 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 101800004637 Communis Proteins 0.000 description 3
- 230000033616 DNA repair Effects 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 239000004367 Lipase Substances 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- 206010028923 Neonatal asphyxia Diseases 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000003444 anaesthetic effect Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000005754 cellular signaling Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 210000003191 femoral vein Anatomy 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 235000019421 lipase Nutrition 0.000 description 3
- 230000037356 lipid metabolism Effects 0.000 description 3
- 210000003712 lysosome Anatomy 0.000 description 3
- 230000001868 lysosomic effect Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 230000003836 peripheral circulation Effects 0.000 description 3
- 210000003660 reticulum Anatomy 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001631 vena cava inferior Anatomy 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 2
- 240000008886 Ceratonia siliqua Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000030886 Traumatic Brain injury Diseases 0.000 description 2
- 229940127090 anticoagulant agent Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000006931 brain damage Effects 0.000 description 2
- 231100000874 brain damage Toxicity 0.000 description 2
- 208000029028 brain injury Diseases 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002615 hemofiltration Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 210000002321 radial artery Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000003270 subclavian artery Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010254 Concussion Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 239000008156 Ringer's lactate solution Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000002253 anti-ischaemic effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000002168 brachiocephalic trunk Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- ZEWYCNBZMPELPF-UHFFFAOYSA-J calcium;potassium;sodium;2-hydroxypropanoic acid;sodium;tetrachloride Chemical compound [Na].[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[Ca+2].CC(O)C(O)=O ZEWYCNBZMPELPF-UHFFFAOYSA-J 0.000 description 1
- 229960004424 carbon dioxide Drugs 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 210000004373 mandible Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 210000001321 subclavian vein Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
- 230000008320 venous blood flow Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
- A61F2007/126—Devices for heating or cooling internal body cavities for invasive application, e.g. for introducing into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/369—Temperature treatment
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Thermal Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
Cette invention, qui a trait à une technique, ainsi qu'à l'équipement correspondant, de surveillance de la température cérébrale ou de la température d'un hémisphère cérébral, concerne, plus particulièrement, une technique et l'équipement correspondant, permettant de surveiller, rapidement et efficacement, la température cérébrale ainsi que de conserver au cerveau une température basse. Cette technique se subdivise en trois étapes. Il s'agit, dans un premier temps, d'une surveillance d'urgence de la température de l'ensemble du corps, permettant une surveillance, notamment sur les lieux d'un accident. La deuxième étape de surveillance sélective de la température cérébrale permet de contrôler celle-ci plus efficacement, notamment en salle d'urgence, et la troisième étape de surveillance du maintien en l'état de la température, permet un contrôle encore plus efficace de la température durant une période prédéterminée.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/072,857 US20020161349A1 (en) | 2000-06-05 | 2002-02-05 | Cerebral temperature control |
| US10/072,857 | 2002-02-05 | ||
| PCT/SE2003/000187 WO2003066137A1 (fr) | 2002-02-05 | 2003-02-05 | Surveillance de la temperature cerebrale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2476382A1 true CA2476382A1 (fr) | 2003-08-14 |
Family
ID=27732324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002476382A Abandoned CA2476382A1 (fr) | 2002-02-05 | 2003-02-05 | Surveillance de la temperature cerebrale |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1480693A1 (fr) |
| AU (1) | AU2003206313A1 (fr) |
| CA (1) | CA2476382A1 (fr) |
| WO (1) | WO2003066137A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7824436B2 (en) | 2005-05-13 | 2010-11-02 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
| US9358150B2 (en) | 2005-05-13 | 2016-06-07 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance |
| US8721699B2 (en) | 2005-05-13 | 2014-05-13 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
| WO2008118864A2 (fr) * | 2007-03-23 | 2008-10-02 | Thermal Therapeutic Systems, Inc. | Dispositif d'hyperthermie portable |
| US8608696B1 (en) | 2009-02-24 | 2013-12-17 | North Carolina State University | Rapid fluid cooling devices and methods for cooling fluids |
| CN102802717A (zh) | 2009-06-19 | 2012-11-28 | 贝尼奇尔股份有限公司 | 用于使鼻腔降温的设备 |
| CN111419528B (zh) * | 2020-04-20 | 2024-08-16 | 首都医科大学宣武医院 | 低温治疗导管和低温治疗系统 |
| JP2024542717A (ja) * | 2021-12-02 | 2024-11-15 | シー・アール・バード・インコーポレーテッド | 目標体温管理システム用の自動化フィードバックのためのシステム、方法、及び装置 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5308320A (en) * | 1990-12-28 | 1994-05-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method |
| US6110139A (en) * | 1997-10-21 | 2000-08-29 | Loubser; Paul Gerhard | Retrograde perfusion monitoring and control system |
| US6042559A (en) * | 1998-02-24 | 2000-03-28 | Innercool Therapies, Inc. | Insulated catheter for selective organ perfusion |
| US6383172B1 (en) * | 1999-04-02 | 2002-05-07 | Coaxia, Inc. | Retrograde venous perfusion with isolation of cerebral circulation |
| SE0002100D0 (sv) * | 2000-06-05 | 2000-06-05 | Jostra Ab | Cerebral temperering |
-
2003
- 2003-02-05 CA CA002476382A patent/CA2476382A1/fr not_active Abandoned
- 2003-02-05 AU AU2003206313A patent/AU2003206313A1/en not_active Abandoned
- 2003-02-05 EP EP03703603A patent/EP1480693A1/fr not_active Withdrawn
- 2003-02-05 WO PCT/SE2003/000187 patent/WO2003066137A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003066137A1 (fr) | 2003-08-14 |
| AU2003206313A1 (en) | 2003-09-02 |
| EP1480693A1 (fr) | 2004-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060052854A1 (en) | Cerebral temperature control | |
| US7189253B2 (en) | Cerebral temperature control | |
| JP4456764B2 (ja) | 熱交換留置カテーテル用冷却システム | |
| US6572640B1 (en) | Method and apparatus for cardiopulmonary bypass patient temperature control | |
| US6648906B2 (en) | Method and apparatus for regulating patient temperature by irrigating the bladder with a fluid | |
| US5879316A (en) | Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method | |
| US9180236B2 (en) | Intra-aortic balloon counterpulsation with concurrent hypothermia | |
| US6607517B1 (en) | Method of inotropic treatment of heart disease using hypothermia | |
| US20020032430A1 (en) | Method and system for treating stroke using hypothermia | |
| JPWO2000030702A1 (ja) | 分離温度調節法のための体外循環装置および体外循環方法 | |
| WO2010111778A4 (fr) | Appareil, système et procédés de traitement sanguin extracorporel pour refroidir de manière sélective le cerveau par rapport au corps pendant un traitement hyperthermique ou pour induire une hypothermie du cerveau | |
| KR20220072853A (ko) | 주입 카테터 및 사용 방법들 | |
| JP3688998B2 (ja) | 無血処置装置 | |
| JPWO2000047251A1 (ja) | 無血処置装置 | |
| EP1480693A1 (fr) | Surveillance de la temperature cerebrale | |
| JP2001029459A (ja) | 液体供給システム | |
| US20160184505A1 (en) | Patient warming system | |
| CN117653488B (zh) | 一种新型epr动物实验平台及其使用方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |